APA

Glamuzina E., Fettes E., Bainbridge K., Crook V., Finnegan N., Abulhoul L. & Vellodi A. (20111024). Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points. : Journal of inherited metabolic disease.

Chicago

Glamuzina Emma, Fettes Emma, Bainbridge Katie, Crook Victoria, Finnegan Niamh, Abulhoul Lara and Vellodi Ashok. 20111024. Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points. : Journal of inherited metabolic disease.

Harvard

Glamuzina E., Fettes E., Bainbridge K., Crook V., Finnegan N., Abulhoul L. and Vellodi A. (20111024). Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points. : Journal of inherited metabolic disease.

MLA

Glamuzina Emma, Fettes Emma, Bainbridge Katie, Crook Victoria, Finnegan Niamh, Abulhoul Lara and Vellodi Ashok. Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points. : Journal of inherited metabolic disease. 20111024.